Possible link between infliximab and optic neuritis

Israel Medical Association Journal

Volumn 10, Issue 6, 2008, Pages 477-478

  Pikkel, Joseph ^a,b  

^a Ziv Hospital   (Israel)

^b NONE   (Israel)

Author keywords

Infliximab; Optic neuritis; Tissue necrosis factor

Indexed keywords

INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; CASE REPORT; COLOR VISION; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DRUG WITHDRAWAL; EYE PAIN; FEMALE; HUMAN; INTRAOCULAR PRESSURE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OPTIC NEURITIS; PRESSURE MEASUREMENT; PUPIL DISEASE; RHEUMATOID ARTHRITIS; SHORT SURVEY; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; OPTIC NEURITIS; RISK FACTORS;

EID: 48949103589     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. Kremer JM. Rational use of new and existing disease-modifying agents in rheumatoid arthritis. Intern Med 2001;134:695-706.
2. Foroozan R, Buono LM, Sergott RC, Savino PJ. Retrobulbar optic neuritis associated with infliximab. Arch Ophthalmol 2002;120: 985-7.
3. Robinson WH, Genovese MC, Moreland LW. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism. Arthritis Rheum 2001;44:1977-83.
4. Fernandez-Arquero M, Arroyo R, Rudio A, et al. Primary association of TNF gene polymorphism susceptibility to multiple sclerosis. Neurology 1999;53:1361-3.
5. Nash PT, Florin TH. Tumor necrosis factor inhibitors. Med J Aust 2005;183:205-8.